U.S. Office REITs Stock News

NYSE:HNI
NYSE:HNICommercial Services

Flourish Chair Launch Tests HNI’s Office Recovery And Margin Hopes

Allsteel, a brand of NYSE:HNI, is launching the Flourish chair as a new collaborative seating option for flexible workplaces. The product is aimed at offices that prioritize adaptability, personal comfort, and connectivity in shared spaces. For investors watching NYSE:HNI, the Flourish launch comes as the stock trades around $30.7, with a mixed return profile. Shares are up 5.0% over the past week, but down 18.6% over the past 30 days and down 27.9% year to date, while the 1-year return is...
NasdaqGS:CHDN
NasdaqGS:CHDNHospitality

Churchill Downs Gaming Exit Talk Puts Focus On Portfolio And Risks

Analyst commentary points to a potential sale, spin-off, or divestiture of Churchill Downs' gaming operations as a way to unlock value for shareholders. The discussion focuses on the company's gaming segment, separate from its well known racing and online wagering assets. No formal process, transaction announcement, or timetable has been reported for NasdaqGS:CHDN at this stage. Churchill Downs, traded as NasdaqGS:CHDN, operates a mix of racing, online wagering, and gaming properties that...
NYSE:RIG
NYSE:RIGEnergy Services

Otway Acceleration Puts Transocean Equinox Utilization And Valuation In Focus

Amplitude Energy has accelerated the drilling schedule for the Transocean Equinox rig at the Artisan gas project in the Otway Basin. The updated plan brings forward the Artisan development well to support an earlier start to gas production, using existing East Coast Supply Project infrastructure. The project involves Beach Energy and Amplitude Energy and represents fresh operational activity for Transocean’s fleet. For investors tracking Transocean (NYSE:RIG), this update ties directly to...
NYSE:LAZ
NYSE:LAZCapital Markets

Is Lazard (LAZ) Now Attractive After A 91% Three Year Share Price Gain?

Wondering whether Lazard at around US$48.06 is genuinely good value or just feels that way after a strong run? This article breaks down what the current price might imply. The stock has moved 5.9% over the last week and 1.6% over the last month, while year to date it is down 3.4% and sits on a 12.2% return over the past year, with a 91.0% return over three years and 27.1% over five years. These returns sit against a backdrop of ongoing headlines around Lazard's role as a global financial...
NYSE:RERE
NYSE:RERESpecialty Retail

A Look At ATRenew (NYSE:RERE) Valuation After Strong Q1 Earnings And Raised Q2 Growth Guidance

ATRenew (RERE) is back in focus after first quarter 2026 results showed net income of CN¥135.09 million and higher earnings per share, alongside second quarter revenue guidance implying 25% to 27% year over year growth. See our latest analysis for ATRenew. The stock has eased in the short term, with the 7 day share price return down 6.77% and the 90 day share price return down 23.40%. The 1 year total shareholder return is 84.88%, which suggests that earlier momentum is cooling after a strong...
NasdaqGS:OSIS
NasdaqGS:OSISElectronic

OSI Systems Wins US$15 Million Order As Acquisition Plans Grow

OSI Systems' Security division received a $15 million task order from a U.S. government customer for cargo and vehicle inspection systems, plus ongoing service and support. The company is also actively looking for acquisitions intended to expand its business and support growth. These developments arrive as NasdaqGS:OSIS trades around $222.10, with the stock up 6.3% over the past week but down 24.1% over the past month. For investors watching NasdaqGS:OSIS, the new government task order...
NYSE:SNDR
NYSE:SNDRTransportation

Has The Recent 44% Rally Left Schneider National (SNDR) Fully Priced?

Wondering if Schneider National at around US$33.40 is still offering value, or if most of the easy gains are already on the table. The stock has returned 3.9% over the last 7 days, 10.3% over 30 days, 23.8% year to date and 44.3% over 1 year, which puts valuation questions front and center for anyone considering it today. Recent coverage has focused on Schneider National as a key player in U.S. trucking and logistics, with investors watching how freight demand and contract pricing shape...
NasdaqGM:FRPT
NasdaqGM:FRPTFood

Is Freshpet (FRPT) Offering A Potential Opportunity After Its 39% One Year Share Price Fall

If you are wondering whether Freshpet's current share price reflects its true worth, it helps to start by looking at what the recent numbers are actually telling you. The stock closed at US$51.58, with the share price up 6.5% over the last week but down 22.0% over the past month, 14.2% year to date, and 39.0% over the last year, which points to shifting sentiment and changing risk perceptions. Recent coverage around Freshpet has focused on its position in the pet food space and how investors...
NasdaqGS:ICLR
NasdaqGS:ICLRLife Sciences

ICON’s New US Clinics Test Early Phase Growth Against Stock Weakness

ICON (NasdaqGS:ICLR) has opened a new 69,500 square foot Clinical Research Unit in San Antonio. The facility includes GMP/GCP pharmacy services, ISO cleanrooms, and expanded early phase clinical trial capacity. New outpatient satellite clinics in Houston and Lawrence extend ICON's reach for trial recruitment and patient access. ICON's new US clinical research expansion comes at a time when the stock has faced sustained pressure, with the share price at $116.78 and the company down 38.1%...
NYSE:BOBS
NYSE:BOBSSpecialty Retail

Is It Time To Reconsider Bob's Discount Furniture (BOBS) After This Year’s Share Price Slide?

If you are wondering whether Bob's Discount Furniture at around US$11.55 offers value or just extra risk, the stock's recent moves and fundamentals give you plenty to weigh up. The share price has been under pressure, with the stock down 2.5% over the last week, 2.1% over the last month, and 32.1% year to date. This may change how you think about its risk and potential reward. Recent coverage has focused on Bob's Discount Furniture as part of broader discussions around U.S. specialty...
NYSE:OHI
NYSE:OHIHealth Care REITs

Is It Too Late To Consider Omega Healthcare Investors (OHI) After Its Strong Multi Year Run?

Investors may be asking whether Omega Healthcare Investors at US$47.90 still offers value after a strong run, or if they might be late to the story. The stock is slightly down 0.9% over the past week, while returns sit at 3.2% over 30 days, 7.6% year to date, 40.8% over 1 year and 94.8% over 5 years. This mix often prompts investors to revisit what they are really paying for. Recent coverage has focused on Omega Healthcare Investors as a healthcare focused REIT, with attention on how its...
NasdaqGS:ROIV
NasdaqGS:ROIVBiotechs

Roivant Shelf Plan Raises Questions On Dilution And Pipeline Funding

Roivant Sciences (NasdaqGS:ROIV) has filed a shelf registration that would allow it to issue nearly $1 billion in new common shares. The filing provides the company with flexibility to conduct future equity offerings when market conditions and funding needs align. This potential issuance could affect shareholder dilution, capital raising plans, and Roivant's ability to fund future projects. Roivant Sciences enters this development with its share price at $29.96 and very large multi-year...